Extended-Release Naltrexone vs. Buprenorphine for Opioid Treatment

NCT02032433 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

570

Enrollment

OTHER

Sponsor class

Conditions

Opioid Use Disorder

Interventions

DRUG: Extended-Release Naltrexone
DRUG: Buprenorphine-Naloxone

Sponsor

NYU Langone Health

Collaborators

[object Object]
[object Object]